Asia Vital Components 미래 성장
Future 기준 확인 6/6
Asia Vital Components (는) 각각 연간 30.2% 및 25.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 30.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 35.3% 로 예상됩니다.
주요 정보
30.2%
수익 성장률
30.1%
EPS 성장률
| Tech 수익 성장 | 18.4% |
| 매출 성장률 | 25.3% |
| 향후 자기자본 수익률 | 35.3% |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 14 Nov 2024 |
최근 미래 성장 업데이트
Results: Asia Vital Components Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 17
Analysts Are Updating Their Asia Vital Components Co., Ltd. (TWSE:3017) Estimates After Its First-Quarter Results
Aug 13Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 17Recent updates
Results: Asia Vital Components Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 17A Look At The Fair Value Of Asia Vital Components Co., Ltd. (TWSE:3017)
Nov 03Asia Vital Components Co., Ltd. (TWSE:3017) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable
Oct 18Is Now The Time To Put Asia Vital Components (TWSE:3017) On Your Watchlist?
Oct 14Is Asia Vital Components (TWSE:3017) A Risky Investment?
Sep 28Analysts Are Updating Their Asia Vital Components Co., Ltd. (TWSE:3017) Estimates After Its First-Quarter Results
Aug 13Asia Vital Components Co., Ltd.'s (TWSE:3017) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Aug 06Is Asia Vital Components Co., Ltd. (TWSE:3017) Worth NT$634 Based On Its Intrinsic Value?
Jul 22Asia Vital Components (TWSE:3017) Is Investing Its Capital With Increasing Efficiency
Jul 04Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce
May 29We Think Asia Vital Components (TWSE:3017) Can Manage Its Debt With Ease
May 21Do Asia Vital Components' (TWSE:3017) Earnings Warrant Your Attention?
Apr 17A Look At The Intrinsic Value Of Asia Vital Components Co., Ltd. (TWSE:3017)
Apr 03Impressive Earnings May Not Tell The Whole Story For Asia Vital Components (TWSE:3017)
Mar 21Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 17Market Participants Recognise Asia Vital Components Co., Ltd.'s (TWSE:3017) Earnings Pushing Shares 29% Higher
Feb 26Is Now The Time To Look At Buying Asia Vital Components Co., Ltd. (TPE:3017)?
Apr 23Does Asia Vital Components (TPE:3017) Have A Healthy Balance Sheet?
Apr 08Asia Vital Components Co., Ltd.'s (TPE:3017) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?
Mar 21Will The ROCE Trend At Asia Vital Components (TPE:3017) Continue?
Feb 16Asia Vital Components Co., Ltd.'s (TPE:3017) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 01
Did You Participate In Any Of Asia Vital Components' (TPE:3017) Fantastic 223% Return ?
Jan 17수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2026 | 115,928 | 14,593 | 14,511 | 14,953 | 7 |
| 12/31/2025 | 96,359 | 11,586 | 10,432 | 14,021 | 13 |
| 12/31/2024 | 71,310 | 8,337 | 6,535 | 10,050 | 10 |
| 9/30/2024 | 67,577 | 7,506 | 8,746 | 12,826 | N/A |
| 6/30/2024 | 64,281 | 6,608 | 10,463 | 13,535 | N/A |
| 3/31/2024 | 62,669 | 5,862 | 9,416 | 12,594 | N/A |
| 12/31/2023 | 59,194 | 5,305 | 6,556 | 10,324 | N/A |
| 9/30/2023 | 57,251 | 4,715 | 4,935 | 8,918 | N/A |
| 6/30/2023 | 56,365 | 4,528 | 3,682 | 8,120 | N/A |
| 3/31/2023 | 55,258 | 4,423 | 4,358 | 8,612 | N/A |
| 12/31/2022 | 56,017 | 4,162 | 5,135 | 8,840 | N/A |
| 9/30/2022 | 53,452 | 3,792 | 3,312 | 6,298 | N/A |
| 6/30/2022 | 50,342 | 3,407 | 2,133 | 4,482 | N/A |
| 3/31/2022 | 49,327 | 3,106 | 1,774 | 3,727 | N/A |
| 12/31/2021 | 47,333 | 2,901 | 1,213 | 2,841 | N/A |
| 9/30/2021 | 45,646 | 2,704 | 2,026 | 4,261 | N/A |
| 6/30/2021 | 43,922 | 2,490 | 2,364 | 4,768 | N/A |
| 3/31/2021 | 42,778 | 2,262 | 1,029 | 3,626 | N/A |
| 12/31/2020 | 39,666 | 1,916 | 2,404 | 4,870 | N/A |
| 9/30/2020 | 39,361 | 1,690 | 2,950 | 4,833 | N/A |
| 6/30/2020 | 39,228 | 1,308 | 1,491 | 3,318 | N/A |
| 3/31/2020 | 37,107 | 972 | 2,185 | 3,816 | N/A |
| 12/31/2019 | 36,534 | 958 | 757 | 2,458 | N/A |
| 9/30/2019 | 34,258 | 871 | -648 | 971 | N/A |
| 6/30/2019 | 31,962 | 800 | 327 | 1,905 | N/A |
| 3/31/2019 | 29,482 | 747 | 274 | 1,719 | N/A |
| 12/31/2018 | 29,067 | 711 | -723 | 971 | N/A |
| 9/30/2018 | 28,673 | 717 | 122 | 1,635 | N/A |
| 6/30/2018 | 27,873 | 776 | N/A | 940 | N/A |
| 3/31/2018 | 27,178 | 811 | N/A | 1,609 | N/A |
| 12/31/2017 | 27,109 | 887 | N/A | 1,806 | N/A |
| 9/30/2017 | 26,750 | 930 | N/A | 1,684 | N/A |
| 6/30/2017 | 26,496 | 898 | N/A | 1,961 | N/A |
| 3/31/2017 | 26,528 | 869 | N/A | 1,230 | N/A |
| 12/31/2016 | 26,504 | 860 | N/A | 2,154 | N/A |
| 9/30/2016 | 26,040 | 826 | N/A | 3,340 | N/A |
| 6/30/2016 | 26,312 | 829 | N/A | 3,133 | N/A |
| 3/31/2016 | 26,194 | 797 | N/A | 3,080 | N/A |
| 12/31/2015 | 25,675 | 741 | N/A | 2,493 | N/A |
| 9/30/2015 | 25,023 | 681 | N/A | 1,124 | N/A |
| 6/30/2015 | 24,317 | 822 | N/A | 1,898 | N/A |
| 3/31/2015 | 24,336 | 820 | N/A | 2,021 | N/A |
| 12/31/2014 | 24,047 | 729 | N/A | 1,962 | N/A |
| 9/30/2014 | 23,739 | 640 | N/A | 2,369 | N/A |
| 6/30/2014 | 22,767 | 355 | N/A | 913 | N/A |
| 3/31/2014 | 21,397 | 282 | N/A | 1,984 | N/A |
| 12/31/2013 | 19,990 | 246 | N/A | 1,505 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: 3017 의 연간 예상 수익 증가율( 30.2% )이 saving rate( 1.1% 보다 높습니다. ).
수익 vs 시장: 3017 의 연간 수익( 30.2% ) TW 시장( 19.4% 보다 빠르게 성장할 것으로 예상됩니다. 19.4% 연간).
고성장 수익: 3017 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.
수익 대 시장: 3017 의 수익(연간 25.3% ) TW 시장( 12.6% 보다 빠르게 성장할 것으로 예상됩니다. 12.6% 연간).
고성장 수익: 3017 의 수익(연간 25.3% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: 3017 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 35.3 %)